The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase 1 study of single agent RX-3117: An oral antimetabolite nucleoside to treat solid tumors.
 
Drew W. Rasco
No Relationships to Disclose
 
Christine Peterson
Employment - Rexahn Pharmaceuticals
Stock and Other Ownership Interests - Rexahn Pharmaceuticals
 
Reza Mazhari
Employment - Cerecor; Rexahn Pharmaceuticals
Leadership - Cerecor
Stock and Other Ownership Interests - Rexahn Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Co-inventor on Patents
 
Ely Benaim
Employment - Rexahn Pharmaceuticals
Leadership - Rexahn Pharmaceuticals
 
Jaime R. Merchan
No Relationships to Disclose